2,6-Di-tert-butyl-p-kresol, crystalline powder
Leverandør: MP Biomedicals
Butylated hydroxytoluene is a phenolic antioxidant.
Butylated hydroxytoluene (BHT) has been shown to inhibit lipid peroxidation. It causes lung injury and promotes tumors in mice, but this may be due to a metabolite of BHT, 6-tert-butyl-2-[2′-(2′-hydroxymethyl)-propyl]-4-methylphenol. Metabolites of BHT have also been reported to induce DNA strand breaks and internucleosomal DNA fragmentation (a characteristic of apoptosis) in cultured cells. In rats, a single intraperitoneal injection of BHT (60 mg/kg body mass) results in a significant increase in nuclear DNA methyl transferase activity in the liver, kidneys, heart, spleen, brain and lungs. Incubation of alveolar macrophages with BHT significantly reduced the level of TNF-α which may explain the mechanism by which this antioxidant reduces inflammation. Preincubation of aspirin-treated platelets with BHT inhibits the secretion, aggregation, and protein phosphorylation induced by protein kinase C activators. BHT was also found to inhibit the initiation of hepatocarcinogenesis by aflatoxin B1.
Insoluble in water; freely soluble in toluene, soluble in methanol, ethanol (100 mg/ml), isopropanol, methyl ethyl ketone, acetone, Cellosolve, benzene and most other hydrocarbon solvents. More soluble in food oils and fats than butylated hydroxyanisole.
NB: Research Use Only (RUO).
Formel:
C₁₅H₂₄O Lagringstemperatur: Romtemperatur |
MDL nummer:
MFCD00011644 CAS-nummer: 128-37-0 |
Spesifikasjon Testresultater
Identity Test | Passes |
FTIR | Conforms to Standard |
Melting Point | 68 - 74 °C |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...